GFAP and its role in Alexander disease
- 6 April 2007
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 313 (10) , 2077-2087
- https://doi.org/10.1016/j.yexcr.2007.04.004
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS42803)
This publication has 83 references indexed in Scilit:
- TRH therapy in a patient with juvenile Alexander diseaseBrain & Development, 2006
- Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damageJournal of Cell Science, 2006
- The Alexander Disease–Causing Glial Fibrillary Acidic Protein Mutant, R416W, Accumulates into Rosenthal Fibers by a Pathway That Involves Filament Aggregation and the Association of αB-Crystallin and HSP27American Journal of Human Genetics, 2006
- Novel mutation of gene coding for glial fibrillary acidic protein in a Japanese patient with Alexander diseaseBrain & Development, 2006
- Astrocyte activation and reactive gliosisGlia, 2005
- Plakins: Goliaths that link cell junctions and the cytoskeletonNature Reviews Molecular Cell Biology, 2004
- Infantile and juvenile presentations of Alexander's disease: a report of two casesActa Neurologica Scandinavica, 1999
- Glial fibrillary acidic protein mRNA isotypes: Expression in vitro and in vivoJournal of Neuroscience Research, 1995
- Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteinsNature, 1986
- Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytesJournal of Neurocytology, 1984